Thomasius F, Palacios S, Alam A, Boolell M, et al. Fracture rates and economic outcomes in patients with osteoporosis prescribed risedronate gastro-resistant versus other oral bisphosphonates: a claims data analysis. Osteoporos Int 2021 Sep 6. pii: 10.1007/s00198-021-06108.
PMID: 34490504